Envoy Medical, Inc.

COCH

Envoy Medical, Inc.

COCH

Insider Sentiment (TTM):

Last Purchase:2026-02-12Last Sale:-Shares Purchased (TTM):20,433,650Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:17,277,757Shares Outstanding:68,934,960Institutional Ownership Pct.:25.06%

Earnings Market Reaction:

Filing Date:2026-08-10Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Related Party	-	1	1	0	-0	1	1	-0	1	0	0	0
Assets Current
Cash And Cash Equivalents At Carrying Value	20	25	4	4	5	5	5	4	2	5	4	7
Restricted Cash Current	-	-	-	-	-	-	-	-	-	-	-	5
Other Restricted Assets	-	-	-	-	-	-	-	-	-	-	-	4
Accounts Receivable Net Current	0	0	0	0	0	0	0	0	0	0	0	0
Other Receivables Net Current	0	0	0	0	0	0	1	0	0	0	0	1
Inventory Net	2	1	2	2	2	2	2	2	2	1	1	1
Cash	-	-	4	-	-	-	5	-	2	5	4	-
Prepaid Expense And Other Assets Current	1	1	1	1	1	1	1	1	1	1	2	1
Assets Current	22	28	6	6	8	8	9	7	5	8	7	20
Property Plant And Equipment Net	1	1	1	1	1	1	1	1	1	0	0	0
Prepaid Expense And Other Assets Noncurrent	-	-	-	0	-	-	-	-	-	-	-	-
Prepaid Expense And Other Assets	0	0	0	-	0	-	0	-	-	-	-	-
Assets	24	30	9	8	10	10	12	9	7	8	8	21
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	2	2	3	3	2	2	2	2	2	1	2	3
Accrued Liabilities Current	10	10	8	6	5	5	4	7	6	6	5	4
Warrants And Rights Outstanding	0	0	0	0	0	0	0	0	0	-	0	-
Derivative Liabilities Current	-	-	-	-	-	-	-	-	-	-	0	0
Product Warranty Accrual Classified Current	0	0	0	0	0	0	0	0	0	-	0	-
Other Liabilities Current	0	0	1	0	0	0	1	-	-	-	1	-
Liabilities Current	13	12	12	9	8	8	8	9	8	7	7	13
Product Warranty Accrual Noncurrent	2	2	2	2	2	2	2	2	2	-	2	-
Derivative Liabilities Noncurrent	-	-	-	-	-	-	-	-	-	-	0	1
Other Liabilities Noncurrent	0	0	0	1	1	1	1	-	-	-	-	-
Liabilities	20	19	20	16	40	35	30	28	19	16	10	16
Temporary Equity
Temporary Equity Carrying Amount Attributable To P…	0	0	0	0	-	-	-	-	-	-	-	-
Stockholders Equity
Common Stock Value	0	0	0	0	0	0	0	-	-	-	-	-
Additional Paid In Capital	330	329	301	298	268	267	266	259	258	258	256	256
Retained Earnings Accumulated Deficit	-326	-319	-313	-306	-298	-291	-285	-278	-270	-265	-257	-251
Accumulated Other Comprehensive Income Loss Net Of…	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0
Stockholders Equity	3	10	-12	-8	-30	-24	-19	-19	-12	-7	-2	5
Liabilities And Stockholders Equity	24	30	9	8	10	10	12	9	7	8	8	21
Series A Preferred Stock	-	0	0	-4	-	4	0	0	-4	0	0	0
Common Class A	-	0	0	-22	-	21	0	0	-19	0	0	-10
Preferred Stock Par Or Stated Value Per Share	-	-	-	0	0	0	-	0	0	0	-	0.01
Preferred Stock Shares Authorized	-	-	-	100	100	100	10	100	-	-	10	-
Preferred Stock Shares Issued	-	-	-	-	4	4	-	-	100	100	-	-
Preferred Stock Shares Outstanding	-	-	-	4	4	4	-	-	-	-	5	5
Common Stock Par Or Stated Value Per Share	-	-	-	-	0	0	-	-	-	-	-	-
Common Stock Shares Authorized	-	-	-	-	400	400	-	-	-	-	-	-
Common Stock Shares Issued	-	-	-	-	22	21	-	-	-	-	-	-
Shares Outstanding	-	-	-	-	22	21	-	19	19	-	20	20

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	2.64%	16.77%	4.19%	-	-	-	-	-	-	-	-	-
2025	18.12%	1.45%	16.67%	-21.23%	-10.27%	-42.53%	20.29%	-0.57%	-7.14%	-5.47%	-13.73%	-16.27%
2024	-19.73%	-21.40%	-13.38%	14.81%	22.59%	-5.56%	3.29%	-27.23%	-22.07%	13.85%	25.38%	7.69%
2023	-	-	-	0.78%	-52.67%	-89.82%	127.47%	96.70%	25.27%	17.73%	-37.27%	-47.95%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	1.73	2.27	0.54	0.64	0.94	1.09	1.18	0.79	0.62	1.10	1.02	1.60
Quick Ratio	1.56	2.07	0.33	0.40	0.67	0.71	0.84	0.51	0.24	0.74	0.61	1.41
Working Capital	9.28M	15.47M	-5.28M	-3.23M	-487.00K	717.00K	1.36M	-1.94M	-3.06M	734.00K	171.00K	7.65M
Leverage & Debt
Debt to Equity	6.13	1.90	-1.67	-2.05	-1.33	-1.43	-1.61	-1.51	-1.54	-2.14	-5.66	3.43
Interest Coverage TTM	-50.15	-21.12	-14.01	-10.35	-11.15	-15.28	-23.60	-49.61	-118.12	-540.89	-	-
Debt Ratio	0.85	0.65	2.37	1.92	4.02	3.33	2.63	2.97	2.84	1.87	1.21	0.77
Efficiency & Turnover
Asset Turnover TTM	0.01	0.01	0.02	0.02	0.03	0.02	0.02	0.02	0.01	0.01	0.06	0.00
Days Sales Outstanding TTM	81.11	56.93	54.52	203.56	178.39	198.86	87.60	200.88	210.30	232.27	64.11	99.21
Receivables Turnover TTM	4.50	6.41	6.69	1.79	2.05	1.84	4.17	1.82	1.74	1.57	5.69	3.68
Per Share Metrics
Diluted EPS TTM	-0.28	-0.41	-1.23	-0.87	-0.93	-0.92	-1.11	-1.27	-0.81	-0.58	-0.31	-2.60
Free Cash Flow Per Share TTM	-0.19	-0.30	-0.79	-0.66	-0.65	-0.85	-1.07	-1.38	-1.12	-1.07	-1.40	-0.83
Dividend Per Share TTM	0.01	0.03	0.13	0.11	0.20	0.17	0.13	0.10	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	-385.51%	-310.68%	-262.66%	-294.23%	-262.16%	-284.43%	-229.78%	-205.04%	-181.46%	-158.25%	-149.68%	-128.93%
Operating Profit Margin TTM	-11,411.11%	-9,881.20%	-9,240.66%	-9,823.56%	-8,872.52%	-9,188.21%	-8,558.22%	-7,708.99%	-6,570.86%	-6,556.23%	-5,809.81%	-4,028.82%
Net Profit Margin TTM	-14,298.07%	-11,972.22%	-11,892.95%	-9,155.29%	-8,964.41%	-9,208.96%	-9,242.22%	-8,526.98%	-4,968.54%	-3,646.88%	-1,216.31%	-7,280.96%
Growth Metrics
Net Revenue Growth (1Y)	-6.76%	10.38%	7.11%	-25.18%	-26.49%	-28.62%	-28.80%	-30.67%	-20.11%	-5.71%	33.33%	603.51%
Net Income Growth (1Y)	48.72%	43.50%	37.83%	-19.67%	32.63%	80.25%	441.04%	-18.81%	-52.96%	-60.85%	-75.86%	-407.54%
EPS Growth (1Y)	-69.43%	-55.61%	11.35%	-31.56%	15.36%	57.20%	254.02%	-55.45%	-74.40%	-32.87%	-80.13%	-404.80%
Valuation Metrics
P/E TTM	-2.78	-1.64	-0.54	-0.89	-1.53	-1.42	-1.29	-2.55	-2.93	-6.73	-5.79	-2.45
P/B TTM	24.95	4.51	-1.26	-2.21	-1.02	-1.14	-1.43	-3.26	-3.54	-9.82	-12.54	14.97
P/S TTM	398.06	195.90	63.79	81.52	136.78	130.78	119.42	217.64	145.35	245.49	70.47	178.68
Market Cap	82.40M	45.84M	15.37M	16.96M	30.37M	27.72M	26.87M	60.50M	43.90M	72.91M	22.27M	71.65M
Enterprise Value	62.72M	20.59M	11.64M	13.40M	25.08M	22.41M	21.39M	56.08M	42.15M	67.97M	18.05M	54.81M
Calculated Values
Free Cash Flow TTM	-19.38M	-20.72M	-18.39M	-14.43M	-13.88M	-18.14M	-20.11M	-25.65M	-20.83M	-19.87M	-17.24M	-8.50M
Net Debt	-19.68M	-25.25M	-3.74M	-3.56M	-5.29M	-5.31M	-5.48M	-4.42M	-1.75M	-4.95M	-4.22M	-16.84M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-02-12Purchase

Owner: Potashnick, Robert

Title: Interim CFO

Shares: 212,500

Price/Share: $0.40

Value: $85,000.00

Shares Owned: 212,500

Relationship: Officer

Ownership: Direct

2026-02-12Purchase

Owner: Kantor, Susan

Title: -

Shares: 96,150

Price/Share: $0.40

Value: $38,460.00

Shares Owned: 174,037

Relationship: Director

Ownership: Direct

2026-02-12Purchase

Owner: Taylor, Glen A

Title: -

Shares: 18,750,000

Price/Share: $0.40

Value: $7,500,000.00

Shares Owned: 21,703,607

Relationship: TenPercentOwner

Ownership: Direct

2026-02-12Purchase

Owner: Brynelsen, Charles

Title: -

Shares: 1,000,000

Price/Share: $0.40

Value: $400,000.00

Shares Owned: 1,050,000

Relationship: Director

Ownership: Direct

2026-02-12Purchase

Owner: Lucas, Brent T.

Title: Chief Executive Officer

Shares: 62,500

Price/Share: $0.40

Value: $25,000.00

Shares Owned: 297,090

Relationship: Director,Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-02-12	Potashnick, Robert	Officer	Interim CFO	Direct	Purchase	212,500	0.40	$85,000.00	212,500	4
2026-02-12	Kantor, Susan	Director	-	Direct	Purchase	96,150	0.40	$38,460.00	174,037	4
2026-02-12	Taylor, Glen A	TenPercentOwner	-	Direct	Purchase	18,750,000	0.40	$7,500,000.00	21,703,607	4
2026-02-12	Brynelsen, Charles	Director	-	Direct	Purchase	1,000,000	0.40	$400,000.00	1,050,000	4
2026-02-12	Lucas, Brent T.	Director,Officer	Chief Executive Officer	Direct	Purchase	62,500	0.40	$25,000.00	297,090	4
2026-02-12	Patel, Mona Chetan	Director	-	Direct	Purchase	312,500	0.40	$125,000.00	332,500	4
2025-06-11	Patel, Mona Chetan	Director	-	Direct	Purchase	2,500	1.47	$3,675.00	20,000	4
2025-06-06	Patel, Mona Chetan	Director	-	Direct	Purchase	10,000	1.46	$14,600.00	17,500	4
2025-05-27	Brynelsen, Charles	Director	-	Direct	Purchase	35,000	1.65	$57,750.00	50,000	4
2024-11-20	Patel, Mona Chetan	Director	-	Direct	Purchase	2,500	2.28	$5,700.00	7,500	4
2024-09-11	Patel, Mona Chetan	Director	-	Direct	Purchase	4,000	3.33	$13,320.00	5,000	4
2023-11-21	Lucas, Brent T.	Director,Officer	Chief Executive Officer	Direct	Purchase	12,380	0.95	$11,761.00	120,831	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

25.06%

Inst. Shares: 17,277,757

Shares Outstanding: 68,934,960

2025-12-31

5.44%

Inst. Shares: 1,264,221

Shares Outstanding: 23,259,598

2025-09-30

10.01%

Inst. Shares: 2,187,546

Shares Outstanding: 21,851,606

2025-06-30

58.91%

Inst. Shares: 12,596,501

Shares Outstanding: 21,383,852

2025-03-31

10.80%

Inst. Shares: 2,303,397

Shares Outstanding: 21,326,609

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	17,277,757	68,934,960	25.06%
2025-12-31	1,264,221	23,259,598	5.44%
2025-09-30	2,187,546	21,851,606	10.01%
2025-06-30	12,596,501	21,383,852	58.91%
2025-03-31	2,303,397	21,326,609	10.80%
2024-12-31	1,764,464	18,790,448	9.39%
2024-09-30	1,032,950	18,616,362	5.55%
2024-06-30	1,162,015	18,599,982	6.25%
2024-03-31	1,148,522	18,599,982	6.17%
2023-12-31	1,837,312	12,295,391	14.94%
2023-09-30	2,864,042	10,214,183	28.04%
2023-06-30	3,876,673	10,122,581	38.30%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Envoy Medical, Inc. (COCH) — SEC Financial Statements & Analysis

Envoy Medical, Inc. (COCH) is a orthopedic, prosthetic & surgical appliances & supplies company. Envoy Medical, Inc. trades on Nasdaq as: COCH, COCHW. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Envoy Medical, Inc. reported a -6.76% year-over-year revenue growth, a Gross Profit Margin of -385.51% (TTM), a Debt-to-Equity ratio of 6.13x, a Price-to-Sales (P/S) ratio of 398.06x (TTM), a Price-to-Book (P/B) ratio of 24.95x (TTM), at a market cap of $82.40M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: -6.76%
Gross Profit Margin TTM: -385.51%
Debt To Equity: 6.13x
P/S TTM: 398.06x
P/B TTM: 24.95x
Market Cap: $82.40M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Envoy Medical, Inc. in?

Envoy Medical, Inc. (COCH) operates in the Orthopedic, Prosthetic & Surgical Appliances & Supplies industry.

What is COCH's market cap?

Envoy Medical, Inc. (COCH) has a market capitalization of $82.40M as of 2026-06-30.

What exchange does COCH trade on?

Envoy Medical, Inc. (COCH) trades on the Nasdaq.